Virginia Wealth Management Group’s AbbVie ABBV Stock Holding History

Virginia Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Hold	920	–	–	0.12%	53
2026 Q1	$200K	Hold	920	–	–	0.11%	53
2025 Q4	$210K	Hold	920	–	–	0.12%	53
2025 Q3	$213K	Buy	+920	New	+$187K	0.12%	52
2023 Q4	–	Sell	-3,058	Closed	-$456K	–	55
2023 Q3	$456K	Buy	3,058 +14	+0.5%	+$2.06K	0.31%	58
2023 Q2	$410K	Buy	3,044 +14	+0.5%	+$2.05K	0.28%	58
2023 Q1	$483K	Buy	3,030 +19	+0.6%	+$2.9K	0.33%	56
2022 Q4	$487K	Buy	3,011 +13	+0.4%	+$1.99K	0.34%	59
2022 Q3	$402K	Buy	+2,998	New	+$430K	0.3%	61

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Virginia Wealth Management Group's ABBV Position: Q2 2026 in Review

Virginia Wealth Management Group held its AbbVie (ABBV) position steady in Q2 2026 at 920 shares worth $232K. The position accounts for 0.12% of the portfolio, ranked #53.

Virginia Wealth Management Group first reported a position in ABBV in Q3 2022 and has held it in 9 quarters since. The position peaked at $487K in Q4 2022. 2,048 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Virginia Wealth Management Group held 920 shares of AbbVie worth $232K as of Q2 2026.
Virginia Wealth Management Group left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.12% of Virginia Wealth Management Group's portfolio in Q2 2026, its #53 holding.
Virginia Wealth Management Group first reported a position in AbbVie in Q3 2022 and has held it in 9 quarters since.
Virginia Wealth Management Group's AbbVie position peaked at $487K in Q4 2022.
2,048 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Virginia Wealth Management Group's 13F filing for Q2 2026, filed 22 Jul 2026.